Hisar Hospital Intercontinental
Hisar Hospital Intercontinental
Turkey, Istanbul
Toluy Ozgumus
9 years of experience
Clinic is certified :
Burkitt's lymphoma treatment cost in Turkey typically includes a bone marrow puncture with cytogenetic analysis ranging from $300 to $400 and chemotherapy protocols running from $2,400 to $3,800. Total expenses depend on the cancer stage and the need for complex interventions like stem cell transplants. Patients often find 40-60% savings compared to the US. Treatment is primarily centered in Istanbul and Ankara.
Typical Burkitt's Lymphoma Treatment Costs in Turkey
Bookimed Expert Insight: High-risk cases requiring aggressive intervention benefit from centers with specialized hematology units. Anadolu Medical Center is ideal because it uses Johns Hopkins Medicine protocols. Professor Zafer Gulbas at Anadolu has an 81% success rate for autologous transplants. For pediatric patients, Professor Savas Kansoy offers expert care, having founded four pediatric bone marrow units. These JCI-accredited facilities provide international-standard care at competitive rates.
Prof. Zafer Gulbaş is a top lymphoma specialist in Turkey, personally performing over 900 bone marrow transplants for hematologic cancers like Burkitt's lymphoma.
Dr. Sevindik trained at Mayo Clinic and has treated Burkitt's lymphoma at top hospitals in Turkey and the US.
Professor Bulent Eser specializes in hematology with a focus on Burkitt's lymphoma at Medical Park Antalya Hospital Complex.
Professor Yesim Yildirim has authored over 80 international publications and book chapters on advanced cancer care, focusing on modern treatments like immunotherapy and targeted therapy.
Turkey is a leading destination for Burkitt's lymphoma due to immediate access to intensive chemotherapy and bone marrow transplantation. JCI-accredited centers follow Johns Hopkins protocols, ensuring high safety standards. Specialized onco-hematologists manage aggressive cases quickly, which is vital for this fast-growing cancer.
Bookimed Expert Insight: Our data shows a major benefit in Turkish all-inclusive transplant packages. Places like Anadolu Medical Center bundle 110 days of post-transplant outpatient care into the price. This is rare and provides a significant safety net during the critical recovery phase after aggressive lymphoma treatment.
Patient Consensus: Patients note the speed of starting chemotherapy is the biggest advantage for this aggressive cancer. They also emphasize confirming your medical team’s specific experience with Burkitt protocols before traveling to Istanbul.
Turkey offers intensive chemotherapy protocols, targeted immunotherapy, and advanced stem cell transplantation for Burkitt lymphoma. Multi-specialty teams at JCI-accredited centers in Istanbul and Ankara manage these rapid-acting treatments. Key protocols include BFM or Murphy regimens often combined with monoclonal antibodies to improve outcomes.
Bookimed Expert Insight: Turkish hematology centers often bundle long-term recovery into their transplant packages. For example, Anadolu Medical Center offers 110 days of post-transplant outpatient care. This is crucial because recovery from aggressive Burkitt protocols requires months of specialized monitoring. Choosing a package with extended follow-up ensures continuous access to your primary medical team during the most vulnerable period.
Patient Consensus: Patients note that initial hospitalization is intensive due to required hydration and 24-hour monitoring. They emphasize checking if a center provides specialized infection control during high-dose chemotherapy cycles.
Turkey's top JCI-accredited hospitals provide specialized treatment for pediatric Burkitt's lymphoma. Centers like Anadolu Medical Center and Memorial Sisli utilize intensive chemotherapy and bone marrow transplants. Facilities often initiate treatment within 7 days. This rapid response is vital for this aggressive malignancy.
Bookimed Expert Insight: Success in treating pediatric Burkitt's lymphoma depends on the center's volume of stem cell procedures. Anadolu Medical Center reports an 81% success rate for autologous transplants. They also provide comprehensive packages covering 110 days of follow-up care. This long-term monitoring is essential for managing recovery after intensive chemotherapy.
Patient Consensus: Families emphasize that immediate chemotherapy initiation and 24-hour pediatric ICU support are more important than luxury amenities. Patients often appreciate when staff are kind during the long treatment process.
Most international patients require a Turkish e-visa or medical visa for Burkitt lymphoma treatment. Turkish clinics facilitate travel by providing official medical invitation letters for visa applications. Standard oncology packages frequently include airport-to-clinic VIP transfers and language assistance to ensure seamless logistics and communication.
Bookimed Expert Insight: A major differentiator in Turkish oncology is the inclusion of long-term housing. For example, Medical Park Antalya bundles up to 90 days of hotel stay. This is vital because Burkitt lymphoma recovery timelines are often unpredictable. These arrangements prevent patients from facing high last-minute accommodation costs during extended treatments.
Patient Consensus: Patients note it is important to verify visa duration against the treatment timeline. They highly recommend using hospital-arranged pickups to simplify the arrival process and reduce initial stress.
Istanbul and Antalya are the main hubs for Burkitt's lymphoma treatment in Turkey. These cities house JCI-accredited facilities specialising in intensive chemotherapy and bone marrow transplantation. Leading centres like Anadolu Medical Center and Memorial Health Group offer specialised diagnostics for this aggressive malignancy. Diagnostics include flow cytometry and PET-CT.
Bookimed Expert Insight: Turkish haematology units often integrate total body irradiation into transplant protocols. This is critical for aggressive lymphomas. Major centres like Anadolu Medical Center maintain an 81% success rate for autologous transplants. Patients should note that many Istanbul packages cost around A$45,500. These packages include 30 days of inpatient monitoring to manage intensive treatment side effects.
Patient Consensus: Patients find the medical staff at clinics like Emsey Hospital highly qualified and kind. Many note that major Istanbul hospitals provide a smoother experience than smaller regional facilities for complex blood disorders.
Turkish oncology centres report overall survival rates between 88% and 90% for paediatric Burkitt's lymphoma. Adult survival typically ranges from 50% to 60%. These outcomes align with international benchmarks. Major JCI-accredited hospitals in Istanbul and Antalya use intensive chemotherapy and bone marrow transplants. This approach helps them achieve these results.
Bookimed Expert Insight: Success in Turkey often stems from high-volume experience with aggressive lymphomas. For example, Dr Mutlu Arat has performed 500+ allogeneic transplants. This high volume allows specialists to manage intensive protocols more safely. Australian patients often find better value in all-inclusive packages. Some include 60 to 125 days of accommodation, which provides price certainty for long recoveries.
Patient Consensus: Patients note the disease is aggressive but responds quickly to chemotherapy in Turkey. Many report long-term remission. They praise the qualified, kind staff at major Turkish hospitals.
Turkish clinics treat Burkitt lymphoma using high-intensity chemoimmunotherapy protocols following ESMO and NCCN guidelines. These involve intensive multi-agent regimens like R-CODOX-M or R-IVAC. Specialists often include rituximab and intrathecal chemotherapy to prevent central nervous system spread. Treatment occurs in JCI-accredited facilities.
Bookimed Expert Insight: Turkish haematology units stand out for their high-volume transplant capacity. Specialists like Dr Zafer Gulbas have supervised 3,000+ procedures. Patients often find better value in all-inclusive packages at JCI-accredited hospitals. These packages bundle 30 to 90 days of hospitalisation and medications into a single price. The price typically ranges from A$42,000 to A$110,000, depending on the transplant type.
Patient Consensus: Patients in Turkey describe the treatment as a demanding, hospital-heavy process. It requires close monitoring for neutropenia and fatigue. They emphasise that qualified staff and intensive protocol-driven care are key. These help manage the emotional and physical toll of the illness.
Treatment for Burkitt's lymphoma in Turkey typically begins within 1 to 7 days of hospital arrival. Major oncology centres in Istanbul and Antalya fast-track this aggressive cancer. Pre-submitting pathology slides and PET-CT scans can help chemotherapy start sooner. It can begin within 24 to 48 hours of landing.
Bookimed Expert Insight: Turkish haematology units are structured for rapid intake. This is because Burkitt's lymphoma cells double every 24 hours. Centres like Memorial Antalya Hospital include extensive 45 to 90-day hospital stays. These are part of their transplant packages. This means patients remain under specialist care during the most critical early phases of intensive treatment.
Patient Consensus: Patients note that treatment starts almost immediately once medically cleared in Turkey. They suggest bringing all existing pathology reports and scans. This avoids repeating tests and saves vital time.